Ayala Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 89 pages Asset Purchase Agreement by and Between Ayala Pharmaceuticals, Inc. and Immunome, Inc. Dated as of February 5, 2024

from 8-K 192 pages Plan of reorganization, merger, acquisition or similar

from 8-K 13 pages Plan of reorganization, merger, acquisition or similar

from 8-K 192 pages Plan of reorganization, merger, acquisition or similar

from 8-K 90 pages Agreement and Plan of Merger Among Advaxis, Inc., Ayala Pharmaceuticals, Inc. and Doe Merger Sub, Inc. Dated as of October 18, 2022

from 425 90 pages Agreement and Plan of Merger Among Advaxis, Inc., Ayala Pharmaceuticals, Inc. and Doe Merger Sub, Inc. Dated as of October 18, 2022